Tanzania						                            
                            
						
 Research Article
												Performance Characteristics of a PCR Assay for the Detection of KRAS Mutations in Formalin-Fixed Paraffin-Embedded Tissue Samples of Non-Small Cell Lung Cancer 						
Author(s): Sung  Lee, Jianli  Cao, Theresa  May, Jingchuan  Li, Lilia  Corona, Nitta  Lee, Yiqiao  Wu, Carrie  Wong, Kelli  DeMartin, Victoria H.  Brophy, Stephen  Soviero and John F.  PalmaSung  Lee, Jianli  Cao, Theresa  May, Jingchuan  Li, Lilia  Corona, Nitta  Lee, Yiqiao  Wu, Carrie  Wong, Kelli  DeMartin, Victoria H.  Brophy, Stephen  Soviero and John F.  Palma             
						
												
				 Introduction: Approximately 25% of non-small cell lung cancer (NSCLC) tumors contain mutations in KRAS. These tumors are insensitive to therapy directed against the epidermal growth factor receptor and appear to be resistant to adjuvant chemotherapy. The current study demonstrates the performance of the cobas® KRAS Mutation Test (cobas test), a TaqMelt polymerase chain reaction (PCR) assay designed to detect 19 mutations in codons 12, 13, and 61.
Methods: To reflect real-world testing conditions, the study used formalin-fixed, paraffin-embedded tissue (FFPET) NSCLC samples for the predominant mutations. DNA blends of cell lines and plasmids were used where FFPET samples were not available.
Results: In the limit of detection study, a correct mutation call rate of ≥95% was obtained with approximately 5% mutant.. Read More»
				  
												DOI:
												 10.4172/2155-9929.1000246 
																	  
Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report